Loss or downregulation of HLA class I expression at the allelic level in acute leukemia is infrequent but functionally relevant, and can be restored by interferon

This publication has 26 references indexed in Scilit:

• Expression and induction of costimulatory and adhesion molecules on acute myeloid leukemic cells
  Experimental Hematology, 2000
• Expression of HLA class I molecules and the transporter associated with antigen processing in hepatocellular carcinoma
  Hepatology, 1996
• Interleukin-10, interleukin-12, and tumor necrosis factor-α differentially influence the proliferation of human CD8 + and CD4 + T-cell clones
  Annals of Hematology, 1996
• Mechanisms of allele‐selective down‐regulation of HLA class I in Burkitt's lymphoma
  International Journal of Cancer, 1995
• Biological‐clinical significance of selective loss of HLA‐class‐I allelic product expression in squamous‐cell carcinoma of the uterine cervix
  International Journal of Cancer, 1994
• A human monoclonal antibody, produced following in vitro immunization, recognizing an epitope shared by HLA‐A2 subtypes and HLA‐A28
  Tissue Antigens, 1993
• Generation of leukemia-reactive cytotoxic T lymphocyte clones from the HLA-identical bone marrow donor of a patient with leukemia.
  The Journal of Experimental Medicine, 1992
• HLA‐DR typing by PCR amplification with sequence‐specific primers (PCR‐SSP) in 2 hours: An alternative to serological DR typing in clinical practice including donor‐recipient matching in cadaveric transplantation
  Tissue Antigens, 1992
• Growth inhibition of clonogenic leukemic precursor cells by minor histocompatibility antigen-specific cytotoxic T lymphocytes.
  The Journal of Experimental Medicine, 1991
• Proposed Revised Criteria for the Classification of Acute Myeloid Leukemia
  Annals of Internal Medicine, 1985